It is not surprising, therefore, that the role of ascorbic acid should have been studied in relation to the pathogenesis and treatment of pressure sores. T. Hunter and K. T. Rajan8 now report the results of their investigations in 18 paraplegic patients aged from 16 to 71 years, of whom nine had pressure sores and nine had not. The results of vitamin C saturation tests in these 18 cases were compared with those obtained on eight normal controls aged from 23 to 35. In addition biopsies of skin and connective tissue were taken from the edge of the pressure sore in seven patients, five of whom were treated surgically immediately afterwards, and in two cases a second biopsy was made after saturation with vitamin C. Seven out of eight controls reached vitamin C saturation in 72 hours, while six out of nine of the group with sores and five out of the nine without sores took longer than 72 hours. Though the authors have not analysed their findings statistically, it seems that there was some difference between the findings in the paraplegic group and in the controls. But no apparent difference was noted in paraplegics with or without pressure sores. Histological studies in the two cases undergoing biopsy before and after saturation with ascorbic acid suggested that the administration of the vitamin considerably increased the formation of collagen. These preliminary and somewhat inconclusive results suggest that the part played by ascorbic acid in relation to the aetiology and healing of pressure sores deserves further study. Medicine, 1955, 253, 847. 8 Munter, T., and Rajan, K. T., Paraplegia, 1971, 8, 211. Chloroquine Myopathy Chloroquine phosphate and subsequently chloroquine sulphate were introduced for the treatment of malaria. They are relatively nontoxic and effective therapeutically and prophylactically in small doses. The chloroquine compounds have since been used in the treatment of rheumatoid arthritis and lupus erythematosus. Much larger doses for periods of a year or more have been followed by reports of toxic symptoms.
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Chloroquine Myopathy
Chloroquine phosphate and subsequently chloroquine sulphate were introduced for the treatment of malaria. They are relatively nontoxic and effective therapeutically and prophylactically in small doses. The chloroquine compounds have since been used in the treatment of rheumatoid arthritis and lupus erythematosus. Much larger doses for periods of a year or more have been followed by reports of toxic symptoms.
In a recent report' of two cases of myopathy after administration of chloroquine the authors describe the clinical course and investigations of one patient with rheumatoid arthritis and another with sarcoidosis. The first patient received 400 mg of chloroquine sulphate daily for two and a quarter years and the second 500 mg daily for one and a half years. Both patients were also receiving steroids. The patient with rheumatoid arthritis developed progressive weakness of all limbs and some difficulty in swallowing. Her hair also went white three months after starting chloroquine. Wasting and weakness of all muscle groups, but worse in the region of the right shoulder, were accompanied by diminished tendon reflexes but no other signs. The wasting progressed after the steroids were stopped. She died of bronchopneumonia one month after the chloroquine was stopped. The second patient already had neurological lesions from sarcoid, confirmed by biopsy of an indurated lesion on her left arm, with bilateral anosmia, optic atrophy, and spastic paraparesis, before starting chloroquine therapy. A year later weakness of her legs had increased, with distinct wasting and weakness of both quadriceps muscles.
Biopsy of an affected muscle confirmed the diagnosis in both cases. Conspicuous vacuolation throughout the whole of the muscle fibres, without any inflammatory change, was accompanied by histochemical changes in degenerating muscle fibres, with alteration in the adenosine triphosphatase and phosphorylase reactions. Instead of the normal positive reactions an alternation between negative and positive reactions was found along the fibres. The process was considered to be preferentially involving granular or type 1 muscle fibres. Experimental chloroquine myopathy shows a similar histochemical selectivity.2 Electron microscopy indicated that chloroquine attacks mitochondria. Moreover it is suggested that heart muscle, which is rich in mitochondria, as are the granular fibres of skeletal muscle, is always affected, and to a greater extent. 3 As both patients were receiving steroids as well as chloroquine it is important to distinguish between steroid myopathy and chloroquine myopathy. The evidence of muscle biopsy with the typical histological and histochemical changes described above helps to distinguish chloroquine myopathy, and to this can be added the fact that chloroquine myopathy may be a severe toxic phenomenon in those receiving large doses over long periods.
There is a natural fear in the hearts of men that cancer may be contagious from man to man or from pet animal to man. Increasing knowledge of the association between viruses and the development of cancers in various animal species has served to reinforce this fear during recent years. A particular cause for concern has been the discovery of C-type RNA viruses as initiating causes of lymphoma and sarcoma in cats.'-' Anxiety was increased by the observation that feline RNA tumour viruses can infect and multiply in human cells growing in tissue culture68 and by the fact that C-type viruses have been seen in the electron microscope in the salivary gland of domestic cats with lymphoma-and indeed in the tissues of apparently healthy cats.9 10 A recent report of negative findings is therefore a source of some comfort. B 
Hydatidiform Mole and Hyperthyroidism
In the past few years many cases have been recorded of tumours arising from tissues lacking an endocrine function yet producing a variety of substances which have a hormonal effect on the patient. Tumours of the bronchus have been shown to contain an adrenocorticotropin' and an antidiuretic substance.2 Sclerosing haemangiomas containing a parathormone-like material,' renal cysts with erythropoetin,4 and sarcomas with insulin-like material' are other examples. Recently it has been shown that tumours of the germinal cells can produce thyroid-stimulating substances.
The thyroid is well known to be responsive to pregnancy. For instance, mild thyrotoxicosis may occur, the basal metabolic rate may be high, the level of protein-bound iodine tends to rise, and the uptake of iodine by the thyroid gland is greater than in the non-pregnant state.' It is possible that the raised basal metabolic rate is due to the increasing oxygen demands of the fetus, the raised protein-bound iodine to an increase in the plasma thyroid-binding globulin produced by oestrogens, and the excess uptake of the iodine to reduction of iodine in the thyroid gland secondary to increased urinary excretion of iodine. But an alternative explanation has recently been advanced. J. M. Hershman and W. R. Starnes7 isolated from normal human placentas a material with thyrotropic activity which they called chorionic thyrotropin.' They showed, moreover, that the average thyrotropic activity in a placenta was the same as in the pituitary gland. The association between pregnancy and thyrotoxicosis extends further, for frank thyrotoxicosis is known to occur in patients with tumours of the placenta.
Probably the first recorded instance of this association was by L. Tisne and his colleagues.8 They showed that in association with hydatidiform mole the uptake of radioiodine by the thyroid gland was higher than in normal pregnancy. and could be accompanied by the clinical signs of thyrotoxicosis. Similar reports9 suggested that the concurrence of these two diseases was more than coincidental, because evacuation of the uterus or treatment of the placental tumour relieved the thyrotoxicosis. Further, the recovery of a thyrotropin from patient's plasma and from the tumour was further proof of a causal relationship. That an association of this kind is not restricted to the female was shown by N Interest has now shifted to identifying the thyroid-stimulating substance in these tumours. Hershman-and H. P. Higgins12 report a further two patients with hydatidiform mole and thyrotoxicosis severe enough to threaten life. Removal of the mole. in both patients cured the thyroid disease, and both have since had normal pregnancies with no disturbance of thyroid function. From one of these patients a thyroid-stimulatory substance was obtained which differed immunologically and chemically from both human pituitary thyrotropin and normal chorionic thyrotropin. This molar thyrotropin, as it has been called, was also unlike long-acting thyroid stimulator (LATS) in its duration of action and its chemical structure, since LATS is now known to be an IgG antibody.
Thus four distinct substances have been isolated which stimulate thyroid activity. Since hydatidiform mole and chorionepithelioma appear to be the source of one of these, we must include these two tumours as parts of the enlarging interface between oncology and endocrinology.
